idarubicin has been researched along with triptolide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Belloc, F; Jeanneteau, M; Lacombe, F; Mahon, FX; Milpied, N; Pigneux, A; Reiffers, J; Uhalde, M | 1 |
| Chen, F; Guo, X; Liu, Y; Shi, P; Wang, S; Wang, W; Xu, B | 1 |
| Deng, M; Feng, J; Jiang, Y; Jiang, Z; Li, P; Liao, N; Shi, P; Song, H; Xu, B; Zha, J; Zhao, H | 1 |
3 other study(ies) available for idarubicin and triptolide
| Article | Year |
|---|---|
Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells.
Topics: Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cytarabine; Diterpenes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Epoxy Compounds; Humans; I-kappa B Proteins; Idarubicin; Leukemia, Myeloid, Acute; Leukocyte Common Antigens; Phenanthrenes; X-Linked Inhibitor of Apoptosis Protein | 2008 |
Low-dose triptolide in combination with idarubicin induces apoptosis in AML leukemic stem-like KG1a cell line by modulation of the intrinsic and extrinsic factors.
Topics: Apoptosis; Blotting, Western; Cell Cycle; Cell Line; Cell Survival; Diterpenes; Epoxy Compounds; Flow Cytometry; Humans; Idarubicin; Immunophenotyping; Leukemia, Myeloid, Acute; Neoplastic Stem Cells; NF-E2-Related Factor 2; Phenanthrenes; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction | 2013 |
Low-Dose Triptolide Enhanced Activity of Idarubicin Against Acute Myeloid Leukemia Stem-like Cells Via Inhibiting DNA Damage Repair Response.
Topics: Animals; Diterpenes; DNA Damage; DNA Repair; Drug Synergism; Epoxy Compounds; Humans; Idarubicin; Leukemia, Myeloid, Acute; Mice; Neoplastic Stem Cells; Phenanthrenes | 2021 |